Zeta Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 28-05-2024
- Paid Up Capital ₹ 3.00 M
as on 28-05-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 5.08 M
as on 28-05-2024
- Revenue -80.36%
(FY 2017)
- Profit -46.21%
(FY 2017)
- Ebitda -217.73%
(FY 2017)
- Net Worth -77.29%
(FY 2017)
- Total Assets 12.99%
(FY 2017)
About Zeta Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹5.08 M.
Shanmugasundaram Muthukumarsamy, Salil Chandana, Markandan Jayaraman, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230HP2005PTC028406
- Company No.
028406
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2005
- Date of AGM
29 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- LocationHimachal Pradesh, Himachal Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Zeta Laboratories?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Markandan Jayaraman  | Director | 13-May-2005 | Current |
| Shanmugasundaram Muthukumarsamy | Director | Current | |
| Salil Chandana | Additional Director | 23-Feb-2017 | Current |
| Ramaiyah Ramesh | Director | Current | |
| Prasanna Venkatesh | Director | 13-May-2005 | Current |
Financial Performance of Zeta Laboratories.
Zeta Laboratories Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 80.36% decrease. The company also saw a substantial fall in profitability, with a 46.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 77.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zeta Laboratories?
In 2017, Zeta Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zoetic Formulations Private LimitedActive 27 years 9 monthsShanmugasundaram Muthukumarsamy and Ramaiyah Ramesh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 18 Feb 2012 | ₹1.58 M | Open |
Punjab National Bank Creation Date: 27 Aug 2007 | ₹2.50 M | Open |
Punjab National Bank Creation Date: 18 Apr 2006 | ₹1.00 M | Open |
How Many Employees Work at Zeta Laboratories?
Unlock and access historical data on people associated with Zeta Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zeta Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zeta Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
